 Fees, Pharmaceutical
"Fees, Pharmaceutical" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Amounts charged to the patient or third-party payer for medication. It includes the pharmacist's professional fee and cost of ingredients, containers, etc.
| Descriptor ID |
D005252
|
| MeSH Number(s) |
N03.219.442.551
|
| Concept/Terms |
Fees, Pharmaceutical- Fees, Pharmaceutical
- Fees, Pharmaceutic
- Fee, Pharmaceutic
- Pharmaceutic Fee
- Pharmaceutic Fees
- Pharmacy Fee
- Pharmaceutical Fees
- Fee, Pharmaceutical
- Pharmaceutical Fee
- Fee, Pharmacy
- Fees, Pharmacy
- Pharmacy Fees
|
Below are MeSH descriptors whose meaning is more general than "Fees, Pharmaceutical".
Below are MeSH descriptors whose meaning is more specific than "Fees, Pharmaceutical".
This graph shows the total number of publications written about "Fees, Pharmaceutical" by people in this website by year, and whether "Fees, Pharmaceutical" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 0 | 1 | 1 | | 2008 | 1 | 0 | 1 | | 2010 | 0 | 2 | 2 | | 2014 | 1 | 0 | 1 | | 2015 | 1 | 1 | 2 | | 2016 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Fees, Pharmaceutical" by people in Profiles.
-
Harrington R, Lee E, Yang H, Wei J, Messali A, Azie N, Wu EQ, Spalding J. Cost-Effectiveness Analysis of Isavuconazole vs. Voriconazole as First-Line Treatment for Invasive Aspergillosis. Adv Ther. 2017 01; 34(1):207-220.
-
Sauer BC, Teng CC, He T, Leng J, Lu CC, Walsh JA, Shah N, Harrison DJ, Tang DH, Cannon GW. Treatment patterns and annual biologic costs in US veterans with rheumatic conditions or psoriasis. J Med Econ. 2016; 19(1):34-43.
-
Winner JG, Carhart JM, Altar CA, Goldfarb S, Allen JD, Lavezzari G, Parsons KK, Marshak AG, Garavaglia S, Dechairo BM. Combinatorial pharmacogenomic guidance for psychiatric medications reduces overall pharmacy costs in a 1 year prospective evaluation. Curr Med Res Opin. 2015; 31(9):1633-43.
-
Ayyagari R, Wei W, Cheng D, Pan C, Signorovitch J, Wu EQ. Effect of adherence and insulin delivery system on clinical and economic outcomes among patients with type 2 diabetes initiating insulin treatment. Value Health. 2015 Mar; 18(2):198-205.
-
Formoso G, Marata AM, Magrini N, Bero L. A clearer view of evidence in treating macular degeneration: off-label policies and independent research. Cochrane Database Syst Rev. 2014 Sep 15; (9):ED000090.
-
Yu AP, Xie J, Bensimon A, Parikh K, Wu EQ, Ben-Hamadi R, Blum S, Haim Erder M. Economic consequence of switching to citalopram after its generic entry for adult patients with major depressive disorder (MDD) treated with escitalopram: a 6-month retrospective study. J Med Econ. 2010; 13(4):599-609.
-
Hurley LP, Lindley MC, Harpaz R, Stokley S, Daley MF, Crane LA, Dong F, Beaty BL, Tan L, Babbel C, Dickinson LM, Kempe A. Barriers to the use of herpes zoster vaccine. Ann Intern Med. 2010 May 04; 152(9):555-60.
-
Kroner BA, Billups SJ, Garrison KM, Lyman AE, Delate T. Actual versus projected cost avoidance for clinical pharmacy specialist-initiated medication conversions in a primary care setting in an integrated health system. J Manag Care Pharm. 2008 Mar; 14(2):155-63.
-
Moynihan R, Bero L, Ross-Degnan D, Henry D, Lee K, Watkins J, Mah C, Soumerai SB. Coverage by the news media of the benefits and risks of medications. N Engl J Med. 2000 Jun 01; 342(22):1645-50.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|